BRPI0612931B8 - composição para aplicação na pele - Google Patents
composição para aplicação na peleInfo
- Publication number
- BRPI0612931B8 BRPI0612931B8 BRPI0612931A BRPI0612931A BRPI0612931B8 BR PI0612931 B8 BRPI0612931 B8 BR PI0612931B8 BR PI0612931 A BRPI0612931 A BR PI0612931A BR PI0612931 A BRPI0612931 A BR PI0612931A BR PI0612931 B8 BRPI0612931 B8 BR PI0612931B8
- Authority
- BR
- Brazil
- Prior art keywords
- skin
- composition
- patient
- application
- biocide
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N25/00—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests
- A01N25/02—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests containing liquids as carriers, diluents or solvents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/075—Ethers or acetals
- A61K31/085—Ethers or acetals having an ether linkage to aromatic ring nuclear carbon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/327—Peroxy compounds, e.g. hydroperoxides, peroxides, peroxyacids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/18—Iodine; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
- A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
- A61L2/0082—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using chemical substances
- A61L2/0088—Liquid substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/02—Local antiseptics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Environmental Sciences (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Dentistry (AREA)
- Agronomy & Crop Science (AREA)
- Pest Control & Pesticides (AREA)
- Plant Pathology (AREA)
- Toxicology (AREA)
- Dermatology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Inorganic Chemistry (AREA)
- Surgery (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
composição para aplicação na pele e método para preparar um paciente para cirurgia. composição para aplicação na pele, compreendendo um biocida ou combinação de biocidas (tais como clorexidina, fenóis halogenados, compostos de amônio quaternário; iodopovidona; piridinotiona de zinco; álcoóis, etc.) e pelo menos um veículo transcutâneo (por exemplo alquil metil sulfóxidos, alquil pirrolidonas, glicóis, glicol éteres, e glicol ésteres) eficazes para transportar o biocida até um microorganismo "residente" sub-epidérmico. também um método para preparar um paciente para cirurgia compreendendo a etapa de tratar uma área da pele do paciente no ou nas adjacências do local de uma incisão cirúrgica pretendida com uma composição eficaz para exterminar mais de 93% de microorganismos tanto "transitórios" como "residentes".
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2005902493A AU2005902493A0 (en) | 2005-05-16 | Method and composition for use in preparation of a patient for surgery | |
AU2005902493 | 2005-05-16 | ||
PCT/AU2006/000553 WO2006122345A1 (en) | 2005-05-16 | 2006-04-28 | Method and composition for use in preparation of a patient for surgery |
Publications (3)
Publication Number | Publication Date |
---|---|
BRPI0612931A2 BRPI0612931A2 (pt) | 2010-12-07 |
BRPI0612931B1 BRPI0612931B1 (pt) | 2020-09-01 |
BRPI0612931B8 true BRPI0612931B8 (pt) | 2021-05-25 |
Family
ID=37430837
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0612931A BRPI0612931B8 (pt) | 2005-05-16 | 2006-04-28 | composição para aplicação na pele |
Country Status (13)
Country | Link |
---|---|
US (2) | US20080175811A1 (pt) |
EP (1) | EP1887864B1 (pt) |
JP (2) | JP2008540581A (pt) |
KR (1) | KR101413138B1 (pt) |
CN (1) | CN101175404B (pt) |
BR (1) | BRPI0612931B8 (pt) |
CA (1) | CA2608344C (pt) |
ES (1) | ES2785999T3 (pt) |
MX (1) | MX2007014372A (pt) |
MY (1) | MY162625A (pt) |
TW (1) | TWI417046B (pt) |
WO (1) | WO2006122345A1 (pt) |
ZA (1) | ZA200710387B (pt) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101969768A (zh) * | 2007-12-17 | 2011-02-09 | 澳大利亚诺万芬研究公司 | 杀病毒组合物 |
TW200932107A (en) * | 2008-01-18 | 2009-08-01 | Dow Global Technologies Inc | Stable, low VOC, low viscous biocidal formulations and method of making such formulations |
BRPI0905707B1 (pt) | 2008-01-18 | 2024-02-27 | Dow Global Technologies Inc | Método para aumentar a solubilidade aquosa de um composto ativo e composição compreendendo um composto ativo |
JP5189402B2 (ja) * | 2008-04-30 | 2013-04-24 | 株式会社マンダム | 抗菌剤組成物及び防臭剤用組成物 |
US9565857B2 (en) | 2010-09-10 | 2017-02-14 | Board Of Regents, The University Of Texas System | Antimicrobial solutions |
IN2014CN03706A (pt) * | 2011-11-16 | 2015-10-09 | 3M Innovative Properties Co | |
DK2814317T3 (da) * | 2012-02-17 | 2019-07-15 | Veloce Biopharma Llc | Fungicide sammensætninger til anvendelse ved behandling af en hudsygdom |
US9161982B2 (en) | 2012-06-18 | 2015-10-20 | Vijon, Inc. | Sanitizer compositions comprising alcohol and an antimicrobial efficacy enhancer |
CN102988236B (zh) * | 2012-11-30 | 2015-06-24 | 哈尔滨医科大学 | 一种神经外科术前头部皮肤准备时所用备皮液及其制备方法和应用 |
KR102143556B1 (ko) * | 2012-12-24 | 2020-08-12 | 노바팜 리서치(오스트레일리아)피티와이리미티드 | 개선된 항균 조성물 |
DE102014115080A1 (de) | 2014-10-16 | 2016-04-21 | Schülke & Mayr GmbH | Verwendung von Fettsäureester zur Verbesserung der antimikrobiellen Wirksamkeit eines alkoholischen Desinfektionsmittels |
US10314914B2 (en) * | 2015-01-20 | 2019-06-11 | Veloce Biopharma, Llc | Iodophor composition and methods of use |
ES2815660T3 (es) * | 2015-03-10 | 2021-03-30 | Covalon Tech Inc | Procedimiento de reducción local de la flora microbiana cutánea |
CN108472505A (zh) * | 2015-12-22 | 2018-08-31 | 3M创新有限公司 | 用于孢子移除的方法 |
CN108498535A (zh) * | 2018-04-04 | 2018-09-07 | 哈尔滨快好药业有限公司 | 一种用于治疗皮肤及黏膜感染的聚维酮碘药物组合物及其制备方法和应用 |
BR102020024967A2 (pt) * | 2020-12-07 | 2022-06-21 | União Brasileira De Educação E Assistência - Mantenedora Da Pucrs | Composição antimicrobiana para uso tópico e/ou externo |
WO2023129596A2 (en) * | 2021-12-29 | 2023-07-06 | Dukal, Llc | Povidone iodine solution and gel, preparation method and application thereof |
Family Cites Families (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4335115A (en) * | 1976-11-01 | 1982-06-15 | The Procter & Gamble Company | Anti-acne composition |
US5656286A (en) * | 1988-03-04 | 1997-08-12 | Noven Pharmaceuticals, Inc. | Solubility parameter based drug delivery system and method for altering drug saturation concentration |
US4975271A (en) * | 1988-12-19 | 1990-12-04 | Vipont Pharmaceutical, Inc. | Muscosal delivery systems for treatment of periodontal disease |
US5624906A (en) * | 1994-12-08 | 1997-04-29 | Lever Brothers Company, Division Of Conopco, Inc. | Oral hygiene compositions comprising heteroatom containing alkyl aldonamide compounds |
US5747058A (en) * | 1995-06-07 | 1998-05-05 | Southern Biosystems, Inc. | High viscosity liquid controlled delivery system |
AUPN814496A0 (en) * | 1996-02-19 | 1996-03-14 | Monash University | Dermal penetration enhancer |
US5916882A (en) | 1997-04-08 | 1999-06-29 | Allegiance Corporation | Povidone iodine (PVP-I) alcohol gel antimicrobial pre-operative skin preparation |
AUPO690997A0 (en) | 1997-05-20 | 1997-06-12 | Novapharm Research (Australia) Pty Ltd | Alkylpolyglucosides containing disinfectant compositions active against pseudomonas microorganism |
US6248343B1 (en) * | 1998-01-20 | 2001-06-19 | Ethicon, Inc. | Therapeutic antimicrobial compositions |
US20020022660A1 (en) * | 1998-01-20 | 2002-02-21 | Hanuman B. Jampani | Deep penetrating antimicrobial compositions |
ATE288682T1 (de) | 1998-09-11 | 2005-02-15 | Surfacine Dev Company Llc | Topisch-dermale antimikrobielle zusammensetzungen |
ZA997202B (en) * | 1998-12-21 | 2000-05-08 | Amar Internat Pvt Ltd L | Pharmaceutical composition. |
US7658942B2 (en) * | 2000-04-12 | 2010-02-09 | The Procter & Gamble Company | Cosmetic devices |
US6951642B2 (en) | 2001-09-28 | 2005-10-04 | 3M Innovative Properties Company | Water-in-oil emulsions with anionic groups, compositions, and methods |
US6846846B2 (en) * | 2001-10-23 | 2005-01-25 | The Trustees Of Columbia University In The City Of New York | Gentle-acting skin disinfectants |
WO2004028502A1 (ja) | 2002-09-27 | 2004-04-08 | Mochida Pharmaceutical Co., Ltd. | 抗真菌剤および抗細菌剤配合洗浄用組成物 |
US20040213751A1 (en) | 2003-03-18 | 2004-10-28 | Schwartz James Robert | Augmentation of pyrithione activity or a polyvalent metal salt of pyrithione activity by zinc-containing layered material |
US8198326B2 (en) * | 2004-09-07 | 2012-06-12 | 3M Innovative Properties Company | Phenolic antiseptic compositions and methods of use |
EP3544200B1 (en) | 2010-04-08 | 2023-09-06 | LG Electronics Inc. | Signal transmsission method and apparatus using codebook in wireless communication system supporting multiple antennas |
-
2006
- 2006-04-28 MX MX2007014372A patent/MX2007014372A/es active IP Right Grant
- 2006-04-28 CA CA2608344A patent/CA2608344C/en active Active
- 2006-04-28 WO PCT/AU2006/000553 patent/WO2006122345A1/en not_active Application Discontinuation
- 2006-04-28 EP EP06721433.8A patent/EP1887864B1/en active Active
- 2006-04-28 BR BRPI0612931A patent/BRPI0612931B8/pt active IP Right Grant
- 2006-04-28 US US11/914,539 patent/US20080175811A1/en not_active Abandoned
- 2006-04-28 ES ES06721433T patent/ES2785999T3/es active Active
- 2006-04-28 KR KR1020077028657A patent/KR101413138B1/ko active IP Right Grant
- 2006-04-28 JP JP2008511501A patent/JP2008540581A/ja active Pending
- 2006-04-28 CN CN200680016994XA patent/CN101175404B/zh active Active
- 2006-05-11 MY MYPI20062193A patent/MY162625A/en unknown
- 2006-05-15 TW TW095117101A patent/TWI417046B/zh active
-
2007
- 2007-11-29 ZA ZA200710387A patent/ZA200710387B/xx unknown
-
2011
- 2011-01-20 US US13/010,197 patent/US9511017B2/en active Active
-
2013
- 2013-04-09 JP JP2013080912A patent/JP5892969B2/ja active Active
Also Published As
Publication number | Publication date |
---|---|
CA2608344C (en) | 2017-07-04 |
TW200721974A (en) | 2007-06-16 |
US9511017B2 (en) | 2016-12-06 |
CA2608344A1 (en) | 2006-11-23 |
JP2008540581A (ja) | 2008-11-20 |
JP2013173758A (ja) | 2013-09-05 |
US20110117048A1 (en) | 2011-05-19 |
WO2006122345A1 (en) | 2006-11-23 |
BRPI0612931B1 (pt) | 2020-09-01 |
CN101175404B (zh) | 2013-03-27 |
KR101413138B1 (ko) | 2014-07-01 |
ES2785999T3 (es) | 2020-10-08 |
TWI417046B (zh) | 2013-12-01 |
ZA200710387B (en) | 2008-12-31 |
MX2007014372A (es) | 2008-02-07 |
EP1887864A4 (en) | 2012-12-19 |
EP1887864B1 (en) | 2020-02-12 |
JP5892969B2 (ja) | 2016-03-23 |
MY162625A (en) | 2017-06-30 |
KR20080019610A (ko) | 2008-03-04 |
CN101175404A (zh) | 2008-05-07 |
US20080175811A1 (en) | 2008-07-24 |
EP1887864A1 (en) | 2008-02-20 |
BRPI0612931A2 (pt) | 2010-12-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI0612931B8 (pt) | composição para aplicação na pele | |
BRPI0618374A2 (pt) | uso de um composto ou um derivado do mesmo farmaceuticamente aceitável, métodos para matar microorganismos clinicamente latentes em um mamìfero, para tratar ou prevenir uma infecção microbiana em um mamìfero, para esterilizar um objeto, para preservar um material inorgánico ou orgánico, para tratar uma doença, para reduzir a dose de agente antimicrobiano convencional requerida para tratar uma infecção microbiana e para tratar uma doença de protozoário em um mamìfero, produto combinado, formulação, uso de um produto combinado, composto, e, processo para a preparação do mesmo | |
MY146081A (en) | Composition and method for pre-surgical skin disinfection | |
WO2011026614A3 (en) | Compositions and methods for disinfecting materials | |
BRPI0509332A (pt) | implantes oculares biodegradáveis com caracterìsticas de liberação a longo prazo | |
ECSP056235A (es) | Composiciones antisepticas, metodos y sistemas | |
BR0209057A (pt) | Composições herbicidas contendo benzoilciclohexanodionas e protetores | |
BRPI0414331A (pt) | método de destruição de bactéria numa área de tratamento do paciente e composição antimicrobiana de terapia fotodinámica | |
WO2012034032A3 (en) | Antimicrobial solutions | |
BR112017006526A2 (pt) | composição e kits para inibição de infecção microbiana patogênica e métodos de usar os mesmos | |
AU2011293307B2 (en) | Passive methods for anti-microbial biological meshes | |
BRPI0922041A8 (pt) | Formulações compreendendo ceftiofur e cetoprofeno ou cetiofur e álcool benzílico. | |
WO2007055950A3 (en) | Polycation-polyanion complexes, compositions and methods of use thereof | |
WO2008039923A3 (en) | Two part antimicrobial boot | |
Güzel et al. | The efficacy of boric acid used to treat experimental osteomyelitis caused by methicillin-resistant Staphylococcus aureus: an in vivo study | |
MX2010006964A (es) | Uso de derivados de guanidina polimericos para el control de microorganismos no deseados en la protección de cultivos. | |
Berretta et al. | Blended chitosan paste for infection prevention: preliminary and preclinical evaluations | |
Grote et al. | Prevention of infection in the current treatment of open fractures: an evidence-based systematic analysis | |
Reich et al. | Sporicidal efficacy of genipin: a potential theoretical alternative for biomaterial and tissue graft sterilization | |
DE102007030103A1 (de) | Verwendung einer synergistischen Zusammensetzung als therapeutisches oder kosmetisches Mittel | |
EP1639971A4 (en) | COMPOSITIONS FOR SKIN PROTECTION | |
CL2008001282A1 (es) | Composicion farmaceutica con actividad antimicrobiana que comprende un aminoacidos n halogenado y un agente antiinflamatorio; uso para prevenir o tratar una infeccion de tejidos, donde dicho tejido es ocular, nasal, seno nasal o dermico o una infeccion respiratoria. | |
BRPI0418380A (pt) | composição de agressina-bioimune para a supressão de infecções por xantomonas em safras de agricultura | |
Leow-Dyke et al. | Evaluation of copper and hydrogen peroxide treatments on the biology, biomechanics, and cytotoxicity of decellularized dermal allografts | |
CN103636596B (zh) | 一种生物膜保护液及其制备与应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] |
Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI |
|
B06U | Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette] | ||
B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 01/09/2020, OBSERVADAS AS CONDICOES LEGAIS. |
|
B16C | Correction of notification of the grant [chapter 16.3 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 28/04/2006 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF |